SOX10 and neoplasm: We therefore explored A-485 effects on the MAPKi-resistant cell lines WM983B BRAFi-R (partial loss of SOX10) and SK-Mel-28 BRAFi-R (SOX10 undetectable; Fig. 5C) to determine whether A-485 could effectively inhibit tumor cell growth in this setting.